1-12 of 12
Chung-Che Chang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adverse Impact of Mutations in DNA Methylation Regulatory Genes on the Prognosis of AML Patients in the 2017 ELN Favorable Risk Group

James Yu, MD, Jingxin Sun, MD PhD, Yuan Du, Chung-Che Chang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16–17.
https://doi.org/10.1182/blood-2020-140038
Published: 2020
Journal Articles

Genomic Landscape of Acute Myeloid Leukemia (AML) on the Basis of 2017 ELN Classification and Other Mutations in Adult AML - Single Healthcare System Data

James Yu, MD, Jingxin Sun, MD PhD, Yuan Du, Chung-Che Chang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 3–4.
https://doi.org/10.1182/blood-2020-139976
Published: 2020
Journal Articles

Plasma Cell CD20 Expression After Autologous Stem Cell Transplantation in Multiple Myeloma: Primary Aberrant Expression or Receptor up-Regulation

Yasser Khaled, MD, Melhem M. Solh, MD, David Ward, Chung-Che Chang, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 4538.
https://doi.org/10.1182/blood.V120.21.4538.4538
Published: 2012
Journal Articles

Is It Time for Arraycgh to Be the First Line Test for Detection of Chromosome Abnormalities in Hematological Disorders-Example Multiple Myeloma

Ankita Patel, Ph.D., Patricia Hixson, PhD, Weimin Bi, Caroline Borgan, Marcus Coyle, Danielle Freppon, David Vo, Jacqueline T. O'Hare, DO, Patricia Luke, Chung-Che Chang, MD, PhD, Sau Cheung
Journal: Blood
Blood (2011) 118 (21): 2543.
https://doi.org/10.1182/blood.V118.21.2543.2543
Published: 2011
Journal Articles

Long-Term Arsenic Trioxide (ATO) Treatment Changes Multiple Myeloma (MM) Cells Micro-RNA and RNA Expression Profiles

Jianguo Wen, PhD, Yongdong Feng, Douglas J Ballon, Chung-Che Chang, MD
Journal: Blood
Blood (2008) 112 (11): 5168.
https://doi.org/10.1182/blood.V112.11.5168.5168
Published: 2008
Journal Articles

Complete Tumor Responses in Lymphoma Patients Who Receive Autologous Cytotoxic T Lymphocytes Targeting EBV Latent Membrane Proteins

Catherine M. Bollard, MD, Maja Stanojevic, BS, Ann M. Leen, PhD, Teresita Lopez, BS, Andrea N. Sheehan, MD, George Carrum, MD, Hao Liu, PhD, Chung-Che Chang, MD, Adrian P. Gee, PhD, Malcolm K. Brenner, MD, PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD, Stephen Gottschalk, MD
Journal: Blood
Blood (2008) 112 (11): 230.
https://doi.org/10.1182/blood.V112.11.230.230
Published: 2008
Journal Articles

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

Clinical Trials & Observations
Catherine M. Bollard, Stephen Gottschalk, Ann M. Leen, Heidi Weiss, Karin C. Straathof, George Carrum, Mariam Khalil, Meng-fen Wu, M. Helen Huls, Chung-Che Chang, M. Victoria Gresik, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop
Journal: Blood
Blood (2007) 110 (8): 2838–2845.
https://doi.org/10.1182/blood-2007-05-091280
Published: 2007
Journal Articles

Quantitative Analysis of Flow Cytometry Immunophenotyping Data for Aiding in the Diagnosis of Myelodysplastic Syndromes (MDS).

Ha T. Nishino, M.D., Youli Zu, M.D., Ph.D., Larry Rice, M.D., Kelty R. Baker, M.D., John J. McCarthy, M.D., Gordon Zeng, M.D., Uday R. Popat, M.D., George Carrum, M.D., Chung-Che Chang, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 4735.
https://doi.org/10.1182/blood.V104.11.4735.4735
Published: 2004
Journal Articles

LMP2-Cytotoxic T Lymphocyte Therapy for Relapsed EBV Positive Lymphoma.

Catherine M. Bollard, MD, Helen M. Huls, BS, Karin C. Straathof, MD, Stephen M. Gottschalk, MD, Teresita Lopez, BS, Chung-Che Chang, MD, PhD, Mary V. Gresik, MD, George Carrum, MD, Malcolm K. Brenner, MD, PhD, Cliona M. Rooney, PhD, Helen E. Heslop, MD
Journal: Blood
Blood (2004) 104 (11): 3276.
https://doi.org/10.1182/blood.V104.11.3276.3276
Published: 2004
Journal Articles

Efficacy of alemtuzumab treatment for refractory T-cell large granular lymphocytic leukemia

Michael D. Rosenblum, James L. LaBelle, Chung-Che Chang, David A. Margolis, Dennis W. Schauer, David H. Vesole
Journal: Blood
Blood (2004) 103 (5): 1969–1971.
https://doi.org/10.1182/blood-2003-11-3951
Published: 2004
Journal Articles

Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia

Clinical Trials & Observations Brief Report
Chung-Che Chang, Jennifer Lorek, Daniel E. Sabath, Ying Li, Christopher R. Chitambar, Brent Logan, Bal Kampalath, Ronald P. Cleveland
Journal: Blood
Blood (2002) 100 (13): 4671–4675.
https://doi.org/10.1182/blood-2002-01-0104
Published: 2002
Journal Articles

Conversion of CD38 and/or myeloid-associated marker expression status during the course of B-CLL: association with a change to an aggressive clinical course

Chung-Che Chang, Ronald P. Cleveland
Journal: Blood
Blood (2002) 100 (3): 1106.
https://doi.org/10.1182/blood-2002-04-1287
Published: 2002